Qlife Holding AB

Equities

QLIFE

SE0013486552

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 11:05:31 2024-05-10 EDT			5-day change	1st Jan Change
0.0027 ^SEK	-10.00%		-10.00%	-86.43%

04-05	Qlife Places Danish Operational Company in Reconstruction Mode	MT
03-25	Sweden's Qlife to Launch Biomarker Testing Platform in South Korea Via Potential Partnership	MT

Qlife Holding AB announced that it has received SEK 4.647035 million in funding from Pensys Ab, Jinderman & Partners AB

August 02, 2023

Qlife Holding AB (publ) announced that it has raised SEK 4.647035 million through convertible loan on August 3, 2023. The transaction included participation from new investors, Jinderman & Partners AB and Pensys Ab. The convertible loan has a 12-month term to maturity on 31 July 2024.

The loan is convertible into shares of the company at a conversion price pf SEK 0.08 per share.

Latest news about Qlife Holding AB

Qlife Places Danish Operational Company in Reconstruction Mode	04-05	MT
Sweden's Qlife to Launch Biomarker Testing Platform in South Korea Via Potential Partnership	03-25	MT
Qlife Signs Letter of Intent with Precision Biosensor	03-25	CI
Qlife Secures Core Patent for Egoo System in EU, UK Markets	02-23	MT
Qlife Announces its Core Patent for Egoo System Grants in EU and Other Countries in European Market, as Well as in United Kingdom	02-23	CI
Qlife Holding AB Announces Update on Collaboration with Hipro Biotechnology	02-16	CI
Qlife Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-09	CI
Qlife Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-09	CI
Qlife Holding AB Postpones the Publication of the Year-End Report for the Financial Year 2023 Until 8 February 2024	02-04	CI
Qlife Enters Collaboration Agreement with Hipro Biotechnology	12-07	CI
Qlife, Hipro Biotechnology Ink Collaboration Deal for Egoo Health; Shares Soar	12-04	MT
Qlife Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Qlife Secures Chinese Partner for Egoo Health; Stock Surges 44%	23-09-14	MT
Qlife Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
Qlife Holding AB announced that it has received SEK 4.647035 million in funding from Pensys Ab, Jinderman & Partners AB	23-08-02	CI
Qlife Holding AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-16	CI
Qlife Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-16	CI
Qlife Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-25	CI
Qlife Plans Layoffs, Cost Reductions; Shares Down 11%	22-09-30	MT
Qlife Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-24	CI
Qlife Plunges 18% as It Seeks Up to $17 Million from Rights Issue	22-08-24	MT
Scanfil Signs Deal To Take Over Medical Device Manufacturing For Qlife	22-08-15	MT
Qlife Signs Outsourcing Agreement with Scanfil to Take over the Continued Production of the Egoo Device	22-08-15	CI
Qlife Receives Milestone Payment of USD 1.23 million from FIND	22-06-27	CI
Qlife Jan Gorm Lisby First to Join Scientific Advisory Board	22-06-20	CI

Chart Qlife Holding AB

Duration

Period

More charts

Company Profile

Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-27 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
QLIFE HOLDING AB	-86.43%	161K
ABBOTT LABORATORIES	-4.84%	182B
MEDTRONIC PLC	+0.56%	110B
BECTON, DICKINSON AND COMPANY	-3.35%	68.11B
DEXCOM, INC.	+2.39%	50.53B
CENCORA, INC.	+9.36%	44.8B
HOYA CORPORATION	+2.70%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+24.51%	32.3B
WEST PHARMACEUTICAL SERVICES, INC.	+3.43%	26.53B
ZIMMER BIOMET HOLDINGS, INC.	-0.32%	24.96B

Other Medical Equipment, Supplies & Distribution